Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.10.14.759179

Implications for Faster Healing with Fewer Applications: Sustained Graft Persistence and Favorable Wound-Healing Biology of a Proprietary Processed Placental Tissue Allograft

Carson, T.·Basu, J.
View original source ↗Export metadata ↓

Abstract

Introduction Placental tissue allografts are widely utilized as wound coverings and barriers. In addition to tissue source, manufacturing and processing methodologies can influence extracellular matrix (ECM) architecture, mechanical stability, protease susceptibility, degradation kinetics, and graft persistence following implantation. An optimized placental tissue allograft should maintain sufficient matrix integrity during the active period of tissue repair while preserving the biological characteristics associated with a favorable wound healing environment. Our previously published work demonstrated that a proprietary processed human amniotic membrane allograft exhibited a more favorable wound healing biologic profile than conventionally processed placental tissue. The finding that no XWRAP treated wound had reached the reapplication threshold at Day 14, considered together with previously demonstrated favorable wound healing biology, provides a mechanistic rationale for the hypothesis that XWRAP may support faster healing with fewer applications over a course of wound management. Methods Graft integrity was evaluated every 2 days for 14 days following application to standardized full thickness excisional wounds in Sprague Dawley rats. XWRAP, a proprietary processed human amniotic membrane allograft, was compared with a donor matched conventionally processed human amniotic membrane comparator and a commercial placental tissue comparator. Graft integrity was scored from 0 to 5, where 0 represented complete graft loss or resorption and 5 represented an intact graft. A score [&le;]1 represented the protocol defined threshold for reapplication during non terminal visits. Longitudinal graft integrity trajectories, original graft degradation, documented reapplications, and the proportion of wounds reaching the reapplication threshold were evaluated. At each visit, graft integrity in XWRAP treated wounds was compared with the pooled comparator groups (primary comparison) and with each comparator separately using animal level Mann Whitney tests, with Holm adjustment across visits; reapplication frequency was compared using exact Poisson rate ratios. Results XWRAP demonstrated markedly greater late phase persistence than both comparator products. At Day 14, mean graft integrity score was 3.88 for XWRAP compared with 0.93 for donor matched conventionally processed amnion and 1.69 for the commercial comparator. From Days 10 through 14, XWRAP graft integrity was significantly greater than both comparators (all p[&le;]0.001), with Cliff's {delta} values of 0.95 to1.00. Compared with the pooled comparator groups, XWRAP graft integrity was significantly greater from Day 8 (3.31 vs. 2.93; p=0.022) through Day 14 (3.88 vs. 1.33; p<0.001); differences at Days 10 to14 remained significant after Holm adjustment, and no significant differences were observed during Days 2 to 6. At the terminal Day 14 assessment, none of the XWRAP treated wounds had reached the protocol defined reapplication threshold (0/16; 0%), compared with 11/14 (79%) wounds treated with donor matched conventional amnion and 5/16 (31%) wounds treated with the commercial comparator. Analysis limited to original grafts demonstrated the same persistence pattern, with Day 14 integrity scores of 3.92, 0.90, and 1.83, respectively. The proportion of wounds at the reapplication threshold at Day 14 was significantly lower with XWRAP than with the pooled comparators (0/16 vs. 16/30; p<0.001). Documented reapplications, all of which occurred during Days 2 to 6, did not differ between XWRAP and the pooled comparators (3.24 vs. 3.40 per 100 wound days; rate ratio 0.95, 95% CI 0.33 to2.53; p=1.00). Discussion Proprietary processing produced a substantially different graft persistence profile, with XWRAP remaining largely intact while comparator tissues progressed toward resorption. Importantly, this greater graft persistence complements our previously published findings demonstrating that XWRAP also produced a more favorable wound healing biologic profile across multiple measures of cellular proliferation, inflammation, tissue injury, and wound resolution. Taken together, these findings support two complementary attributes of XWRAP: sustained graft persistence and favorable wound healing biology. The finding that no XWRAP treated wound had reached the reapplication threshold at Day 14 provides a mechanistic rationale for the hypothesis that this combination may extend application intervals and reduce application requirements over a course of wound management.

Explore related subjects

bioengineeringPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Carson, T., Basu, J.. 2026-10-16. Implications for Faster Healing with Fewer Applications: Sustained Graft Persistence and Favorable Wound-Healing Biology of a Proprietary Processed Placental Tissue Allograft. https://doi.org/10.64898/2026.10.14.759179

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Mesoscale Soft Robotics for Mechanically Perturbing and Functionally Monitoring Responses in Human Organoids

Human organoids represent promising models for studies of significance to the biology and medical communities. Of the existing approaches for monitoring organoids, none offers the ability to apply programmable mechanical forces while simultaneously recording multi-modal physiological responses, of relevance to phenomena spanning from traumatic brain injuries to cardiac rhythm disorders. Here, we present a mesoscale soft robotic organoid interface that enables programmable delivery of forces to organoids of diverse shapes, and to map electrophysiological activity and mechanical responses. The platform combines actuation elements with integrated sensors for quantitative measurement and control. Studies using this technology reveal that spheroidal cortical organoids exhibit distinct responses to mechanical trauma, including silencing, recovery, and changes in neuronal firing patterns. Additional experiments on cardiac ring tissues demonstrate that sustained stretching induces beat-to-beat rhythm variability and altered conduction. The results establish a framework for investigating force-triggered transitions between physiological and disease-like states in human tissue models.

bioengineering↗
bioRxiv2026

Few-shot regulatory sequence design with a genomic language model

A central challenge in generative biology is translating knowledge learned from natural sequences and experiments into designs with desired functions. In-context learning (ICL) is an emergent capability of large language models that allows them to adapt to new tasks from a few examples without additional training, enabling these models to become general-purpose learners. Here, we show that the genome language model, Evo 2, exhibits generative ICL in biological sequence design. Prompting with just tens of examples conditions Evo 2 to generate novel and diverse regulatory DNA sequences without any additional training. Mechanistic analysis suggests that genomic ICL may originate from induction, similar to phenomena observed in natural language. Reinforcement learning leveraging sequence-to-function models as experiment-derived rewards further strengthens ICL. We first validate this approach by generating enhancers that drive cell-type-specific gene expression in three human cell lines. Extending this approach in vivo, enhancers designed using human regulatory element data selectively label layer 5 extratelencephalic neurons in the mouse cortex with high specificity and stronger activity than existing enhancers. Our study provides evidence of emergent properties in genomic sequence models and introduces a promising approach for improving functional conditioning in generative biology.

bioengineering↗
bioRxiv2026

IOP-independent treatment for neurodegeneration in glaucoma using optimized ROS-scavenging microparticles for sustained release of erythropoietin

Glaucoma is a slow-progressing neurodegenerative disease of the optic projection to the brain and a leading cause of blindness worldwide. Current treatments are targeted towards lowering intraocular pressure (IOP), the only known, modifiable risk factor; however, this strategy is ineffective in many patients. An early hallmark of glaucomatous neurodegeneration is increased reactive oxygen species (ROS), representing an alternative opportunity for intervention to halt or slow disease progression. In this work, we optimize a ROS-scavenging copolymer, poly(propylene sulfide-co-ethylene sulfide) (PPSES), for formulation of size-controlled, stabilized, antioxidant microparticles (MPs) for sustained release of the protein erythropoietin (EPO). EPO promotes biological antioxidant defense via activation of NRF2-mediated transcription of antioxidant genes. This MP system overcomes the short half-life of EPO and leverages the combined benefits of bioactive EPO with long-lasting, inherently antioxidant PPSES MPs. The lead EPO-MP formulation preserves neurons in both mouse and non-human primate models of glaucoma through suppression of oxidative stress and optic nerve degeneration. EPO-loaded PPSES MPs represent a translationally relevant therapy for long-term management of glaucoma independent of IOP.

bioengineering↗